BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 35669855)

  • 21. [Mechanism of gypenoside XVII against cerebral ischemia/reperfusion injury based on nuclear factor erythroid 2-related factor 2/antioxidant responsive element signaling pathway].
    Wang W; Xu Y; Xu S; Mao L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):293-298. PubMed ID: 36916343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of SETD7 protects cardiomyocytes against hypoxia/reoxygenation-induced injury through regulating Keap1/Nrf2 signaling.
    Dang Y; Ma X; Li Y; Hao Q; Xie Y; Zhang Q; Zhang F; Qi X
    Biomed Pharmacother; 2018 Oct; 106():842-849. PubMed ID: 30119254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demethylnobiletin ameliorates cerebral ischemia-reperfusion injury in rats through Nrf2/HO-1 signaling pathway.
    Huang D; Awad ACA; Tang C; Chen Y
    Environ Toxicol; 2024 Mar; 39(3):1335-1349. PubMed ID: 37955318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperoside protects mouse spermatocytes GC-2 cells from oxidative damage by activating the Keap1/Nrf2/HO-1 pathway].
    Zhu Y; Wang T; Dai N; Deng M; Liu H; Tong X; Li L
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):673-680. PubMed ID: 35673910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
    Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
    Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcitriol Ameliorates Brain Injury in the Rat Model of Cerebral Ischemia-Reperfusion Through Nrf2/HO-1 Signalling Axis: An in Silico and in Vivo Study.
    Vahidinia Z; Khassafi N; Tameh AA; Karimian M; Zare-Dehghanani Z; Moradi F; Joghataei MT
    J Stroke Cerebrovasc Dis; 2022 Jun; 31(6):106331. PubMed ID: 35306470
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Pan H; Niu L; Wu Y; Chen L; Zhou X; Zhao Y
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platycodin D inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury.
    Wang Y; Che J; Zhao H; Tang J; Shi G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):3219-3224. PubMed ID: 30146261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-Carnitine Reduces Myocardial Oxidative Stress and Alleviates Myocardial Ischemia-Reperfusion Injury by Activating Nuclear Transcription-Related Factor 2 (Nrf2)/Heme Oxygenase-1 (HO-1) Signaling Pathway.
    Zhao T; Chen S; Wang B; Cai D
    Med Sci Monit; 2020 May; 26():e923251. PubMed ID: 32452468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Icaritin activates Nrf2/Keap1 signaling to protect neuronal cells from oxidative stress.
    Xu Y; Lu X; Zhang L; Wang L; Zhang G; Yao J; Sun C
    Chem Biol Drug Des; 2021 Jan; 97(1):111-120. PubMed ID: 32654377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginsenoside Rb3 protects cardiomyocytes against hypoxia/reoxygenation injury via activating the antioxidation signaling pathway of PERK/Nrf2/HMOX1.
    Sun J; Yu X; Huangpu H; Yao F
    Biomed Pharmacother; 2019 Jan; 109():254-261. PubMed ID: 30396083
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Hu X; Mu L; Zhu L; Chang X; Nie L; Wang L; Li G
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymus quinquecostatus Celak. ameliorates cerebral ischemia-reperfusion injury via dual antioxidant actions: Activating Keap1/Nrf2/HO-1 signaling pathway and directly scavenging ROS.
    Fan S; Liu X; Wang Y; Ren X; Liu Y; Dong Y; Fan Q; Wei J; Ma J; Yu A; Song R; Sui H; Shen M; Fang F; Xia Q; She G
    Phytomedicine; 2021 Oct; 91():153673. PubMed ID: 34416627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitexin Improves Cerebral ischemia‑reperfusion Injury by Attenuating Oxidative Injury and Ferroptosis via Keap1/Nrf2/HO-1signaling.
    Guo L; Shi L
    Neurochem Res; 2023 Mar; 48(3):980-995. PubMed ID: 36435955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-34b Protects Against Focal Cerebral Ischemia-Reperfusion (I/R) Injury in Rat by Targeting Keap1.
    Huang R; Ma J; Niu B; Li J; Chang J; Zhang Y; Liu P; Luan X
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):1-9. PubMed ID: 30539753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paeoniflorin alleviates hypoxia/reoxygenation injury in HK-2 cells by inhibiting apoptosis and repressing oxidative damage via Keap1/Nrf2/HO-1 pathway.
    Xing D; Ma Y; Lu M; Liu W; Zhou H
    BMC Nephrol; 2023 Oct; 24(1):314. PubMed ID: 37884904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urolithin B, a gut microbiota metabolite, protects against myocardial ischemia/reperfusion injury via p62/Keap1/Nrf2 signaling pathway.
    Zheng D; Liu Z; Zhou Y; Hou N; Yan W; Qin Y; Ye Q; Cheng X; Xiao Q; Bao Y; Luo J; Wu X
    Pharmacol Res; 2020 Mar; 153():104655. PubMed ID: 31996327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA miR-24-3p Reduces Apoptosis and Regulates Keap1-Nrf2 Pathway in Mouse Cardiomyocytes Responding to Ischemia/Reperfusion Injury.
    Xiao X; Lu Z; Lin V; May A; Shaw DH; Wang Z; Che B; Tran K; Du H; Shaw PX
    Oxid Med Cell Longev; 2018; 2018():7042105. PubMed ID: 30622671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costunolide Protects Myocardium From Ischemia Reperfusion Injury by Inhibiting Oxidative Stress Through Nrf2/Keap1 Pathway Activation.
    Li W; Luo Y; Huang Z; Shen S; Dai C; Shen S; Qi X; Liang G; Luo W
    J Cardiovasc Pharmacol; 2023 Aug; 82(2):117-127. PubMed ID: 37000981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.